Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary M Coppola

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Thiourea-based gemfibrozil analogues as HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Thiourea-based gemfibrozil analogues as HDL-elevating agentsGary M Coppola, Robert E Damon, J Bruce Eskesen, et al.
Journal of Medicinal Chemistry|October 14, 2005
Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Gary M Coppola, Paivi J Kukkola, James L Stanton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H Serrano-Wu, Gary M Coppola, Yongjin Gong, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.
Pageof 1